rly-2608
relay therapeutics
['rly2608 ']
closer look at the strikingly stable circulating glucose levels in pik3ca mutant-selective #rly2608 phase 1. no dose reductions needed for hyperglycemia. #aacr23 
Director, Kabara Cancer Research Institute; Dr. Jon & Betty Kabara Endowed Chair in Precision Oncology. Gundersen Medical Foundation. Opinions are my own.